These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6774840)

  • 1. Variable in vivo binding of valproic acid in epilepsy patients being medicated with other anticonvulsants.
    Haidukewych D; Rodin EA
    Clin Chem; 1980 Oct; 26(11):1634-5. PubMed ID: 6774840
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.
    Kober A; Olsson Y; Sjöholm I
    Mol Pharmacol; 1980 Sep; 18(2):237-42. PubMed ID: 6775182
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
    Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
    J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition between valproate & phenytoin for plasma protein binding.
    Jaffery NF; Ahmad SN; Jailkhani BL
    Indian J Med Res; 1986 Apr; 83():426-8. PubMed ID: 3087873
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of coadministered antiepileptic drugs on free fractions of phenobarbital and valproic acid in epileptic children.
    Kodama S; Sadahiro N; Yokoyama S; Komatsu M; Konishi H; Tanaka K; Tanaka K; Matsuo T
    Kobe J Med Sci; 1986 Oct; 32(5):141-9. PubMed ID: 3102832
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial free and plasma valproic acid and phenytoin monitoring and drug interactions.
    Haidukewych D; Rodin EA
    Ther Drug Monit; 1981; 3(3):303-7. PubMed ID: 6798720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate and palmitate binding to serum albumin in valproate-treated patients. Relation to obesity.
    Vorum H; Gram L; Honoré B
    Epilepsy Res; 1993 Sep; 16(1):55-64. PubMed ID: 8243440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein binding of diphenylhydantoin in man. II. Interaction with sodium valproate in epileptic patients.
    Gatti G; Lecchini S; Frigo GM; Visintini D; Calzetti S; Lombardi M; Cattaino G
    Farmaco Prat; 1979 Jan; 34(1):46-8. PubMed ID: 378689
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased plasma protein binding of phenytoin in patients on valproic acid.
    Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
    Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
    Sobaniec W
    Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein binding of diazepam and its displacement by valproic acid in vitro.
    Dhillon S; Richens A
    Br J Clin Pharmacol; 1981 Oct; 12(4):591-2. PubMed ID: 6794588
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticonvulsive combined therapy (author's transl)].
    Deisenhammer E; Sommer R; Nitsche V
    Wien Klin Wochenschr; 1980 Jan; 92(1):23-4. PubMed ID: 6769255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on cerebrospinal fluid and saliva to serum concentration ratios of anticonvulsants--Phenytoin, Phenobarbital, Valproic Acid and Primidone in epileptic patients].
    Kido H
    Seishin Shinkeigaku Zasshi; 1982; 84(9):661-79. PubMed ID: 6820506
    [No Abstract]   [Full Text] [Related]  

  • 17. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
    ter Heine R; van Maarseveen EM; van der Westerlaken MM; Braun KP; Koudijs SM; Berg MJ; Malingré MM
    J Child Neurol; 2014 Jun; 29(6):803-10. PubMed ID: 23670246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.
    Miles MV; Snead OC; Thorn MD
    Clin Pharm; 1988 Sep; 7(9):688-93. PubMed ID: 3149223
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of total and free anticonvulsant serum levels in clinical practice.
    Beran RG; Lewis JH; Nolte JL; Westwood AP
    Clin Exp Neurol; 1985; 21():69-77. PubMed ID: 3939613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients.
    Monks A; Richens A
    Clin Pharmacol Ther; 1980 Jan; 27(1):89-95. PubMed ID: 6985856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.